Naturhouse Health's EBIT per Share for the
six
months ended in Dec. 2025 was €0.09.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.23.
During the past 12 months, the average EBIT per Share Growth Rate of Naturhouse Health was 0.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 1.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -2.90% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -9.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Naturhouse Health's EBIT per Share or its related term are showing as below:
XMAD:NTH'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -20.1 Med: -8.25 Max: 35.7
Current: 1.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Naturhouse Health was 35.70% per year. The lowest was -20.10% per year. And the median was -8.25% per year.
XMAD:NTH's 3-Year EBIT Growth Rate is ranked worse than 61.86% of 1581
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs XMAD:NTH: 1.10
Naturhouse Health (XMAD:NTH) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Naturhouse Health EBIT per Share Related Terms
Naturhouse Health EBIT per Share Historical Data
* Premium members only.
The historical data trend for Naturhouse Health's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.23
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturhouse Health (XMAD:NTH) has a EBIT per Share of €0.23 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Naturhouse Health and its competitors. According to the industry distribution chart, Naturhouse Health ranks #978 out of 1581 companies in the Consumer Packaged Goods industry, placing it in the top 61.9%.
Is Naturhouse Health's EBIT per Share too high?
Naturhouse Health's current EBIT per Share is €0.23. Based on the distribution chart, Naturhouse Health ranks #978 out of 1581 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Naturhouse Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's EBIT per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Naturhouse Health ranks #978 out of 1581 companies for EBIT per Share. This places Naturhouse Health in the lower half of its industry. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Naturhouse Health and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturhouse Health's current EBIT per Share is €0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.56 — trading 58% above its estimated fair value. The current EBIT per Share is €0.23. Naturhouse Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current EBIT per Share is €0.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?
Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued.
The current stock price of €2.56 is trading 58% above its estimated GF Value™ of €1.62.
GuruFocus considers Naturhouse Health to be Significantly Overvalued.
Key valuation signals for XMAD:NTH:
EBIT per Share: €0.23
GF Value™: €1.62 vs. price of €2.56 (58% above fair value)
No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
81GF Score
Get the complete analysis for XMAD:NTH
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:NTH has been successfully added to your 
